Contact Us: 01282 426380
KM Financial Solutions | UPDATE 1-Pfizer in deal with Allogene to develop cancer cell therapies
13743
post-template-default,single,single-post,postid-13743,single-format-standard,qode-quick-links-1.0,ajax_fade,page_not_loaded,,qode_grid_1300,footer_responsive_adv,hide_top_bar_on_mobile_header,qode-child-theme-ver-1.0.0,qode-theme-ver-11.2,qode-theme-bridge,wpb-js-composer js-comp-ver-5.2.1,vc_responsive
 

UPDATE 1-Pfizer in deal with Allogene to develop cancer cell therapies

02 Apr UPDATE 1-Pfizer in deal with Allogene to develop cancer cell therapies

Posted at 17:14h in News by
0 Likes
April 3 (Reuters) – Pfizer Inc said on Tuesday it
would take a 25 percent stake in Allogene Therapeutics to
accelerate the development of CAR T cell therapies sourced from
donors instead of patients.

No Comments

Sorry, the comment form is closed at this time.